Since its outbreak, the U.S.-China trade war has evolved from a simple tariff dispute into a structural adjustment of the global industrial chain. This deep-seated conflict, involving technology, manufacturing, and public policy, has not only altered the international economic and trade landscape but has also had a profound impact on industrial resilience and the public health resource supply chain in North America. According to an analysis by German expert Doris Fischer, the core of this trade war is not merely about trade surpluses or deficits, but rather the United States' caution and countermeasures against China's dominant position in the industrial chain.

In North America, particularly among policymakers in U.S. states such as the Commonwealth of Massachusetts, there is a forced effort to strike a balance between highly globalized supply chain dependencies and national security and public health resilience.

Multiple sources confirm that current global geopolitical trends are profoundly affecting corporate investment layouts. The Taiwan External Trade Development Council (TAITRA) points out that integrating global geopolitical trend analysis with industrial pulse monitoring has become a vital support for corporate decision-making. In North America, enterprises and government departments are actively reconstructing supply chain paths through digital trade platforms and cross-border e-commerce portals. This shift is not only intended to circumvent tariff barriers but also to ensure that the supply of critical materials, such as medical devices and pharmaceutical raw materials, remains uninterrupted during public health events or other global crises.

Public information provided on the official websites of various U.S. states indicates that the government is strengthening guidance for local industries, attempting to reshore or localize key industrial chains to reduce excessive reliance on a single overseas supply source.

However, there are significant differences among sources regarding the extent and subsequent effects of the trade war. Some perspectives argue that the U.S. initiated the trade war based on concerns over China's industrial dominance; yet other views point out that China's diplomatic entrustment and intentions regarding foreign ministers imply more complex negotiation strategies, making the trajectory of the trade war full of variables. Furthermore, discussions regarding "withdrawal" policies present vastly different interpretations in various media reports. What remains to be confirmed is whether these policies, as North America continues to promote industrial chain restructuring, can effectively mitigate the risk of supply chain disruptions in the public health sector, or if they will lead to rising costs due to excessive protectionism, thereby affecting the affordability and accessibility of public health.

For North America, the specific impact of this shift is reflected in the reshaping of medical device and pharmaceutical supply chains. Regions with strong biotechnology and medical industry foundations, such as Massachusetts, are actively using policy incentives to attract high-value-added manufacturing back to the region. This is not only an economic policy but is also viewed as a crucial component of public health security. As global trade rules are constantly being rewritten, North American companies must establish more flexible operating models between digital trade and physical supply chains. While this shift can enhance regional autonomous supply capabilities, it may also face challenges such as inconsistent technical standards, market access restrictions, and increased costs of cross-border cooperation.

There is clear tension between different viewpoints. Proponents argue that the localization of industrial chains is a necessary means to safeguard national security and public health resilience; opponents, however, worry that an overemphasis on protectionism will undermine the efficiency dividends brought by globalization and may trigger a new round of trade retaliation, ultimately harming consumer rights. Experts caution against over-interpreting the impact of a single policy on the overall economy, as the essence of the trade war is a multi-layered game involving geopolitics, technological competition, and social welfare. When evaluating North American public health and industrial policies, one must consider the complexity of global supply chains and avoid using simplified logic to deduce long-term trends.

Future observation should focus on whether North American state governments will further strengthen industrial chain integration with allied nations, and the practical efficacy of these policies in addressing future public health challenges. Additionally, with the proliferation of digital trade tools, how companies utilize intelligent data insights to optimize supply chain layouts will be the key to determining North American industrial competitiveness. We will continue to monitor the evolution of U.S.-China trade relations and the chain reactions they bring to global public health and North American trade policy, while closely tracking the execution details and industrial feedback following the implementation of various policies.